News | Heart Failure | March 03, 2021

European Union Allows MRI Scans of Heart Failure Patients With Impulse Dynamics Implanted Optimizer Smart Devices

Impulse Dynamics Optimizer Smart device is an implantable device that helps optimize cardiac pumping action in heart failure patients.

Impulse Dynamics Optimizer Smart device is an implantable device that helps optimize cardiac pumping action in heart failure patients.


March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization, approved labeling for the Optimizer Smart device for conditional full-body magnetic resonance imaging (MRI) scans utilizing 1.5 Tesla scanners in the European Union (EU). DEKRA, known for ensuring the safe use of medical devices in global markets, has given heart failure (HF) patients with the Optimizer Smart device implant the opportunity to receive whole-body MRI required to diagnose anatomical and physiological processes.

The commercial significance of this accomplishment affords not only HF patients with peace of mind but healthcare practitioners with unhindered access to perform full-body MRI scans. Additionally, the Optimizer’s safe use approval opens the door to extensive use with other MRI-conditional devices. 

“The MRI full-body certification by DEKRA is a significant step for Impulse Dynamics. This gives patients and physicians the assurance that important diagnostic examinations can be performed for the benefit of patients, independent of the CCM therapy,” said Jens Kalender, vice president of commercial DACH for Impulse Dynamics.

Additionally, Deborah Morley, Ph.D., vice president of regulatory affairs and quality assurance exoplained, “Attainment of whole-body MRI-conditional CE labeling is a major milestone for Impulse Dynamics made possible through positive cooperation with the notified body, DEKRA, and our top-notch engineering team. We look forward to many more such achievements in the near future, advancing CCM therapy to provide hope for heart failure patients worldwide.”

For more information: www.impulse-dynamics.com

Related Content

News | EP Lab

October 6, 2021 – Biosense Webster announced the first cases using a radiofrequency balloon ablation catheter were ...

Home October 06, 2021
Home
News | EP Lab
October 1, 2021 — The European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization ...
Home October 04, 2021
Home
Videos | EP Lab
Khaldoun Tarakji, M.D., MPH, associate section head, cardiac electrophysiology, Heart and Vascular Institute at ...
Home October 04, 2021
Home
Feature | EP Lab

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Home September 28, 2021
Home
News | EP Lab

September 1, 2021 — Stereotaxis and Shanghai Microport EP Medtech Co., Ltd. announced a broad collaboration to advance ...

Home September 01, 2021
Home
News | EP Lab

August 9, 2021 – Results from an international clinical trial show a significant reduction in risk of ventricular ...

Home August 09, 2021
Home
Feature | EP Lab

July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them ...

Home August 09, 2021
Home
News | EP Lab | By Dave Fornell, Editor

August 5, 2021 — A prospective, non-randomized, multicenter, first-in-human clinical study found good diagnostic and ...

Home August 05, 2021
Home
News | EP Lab

August 3, 2021 — A subgroup analysis of the EAST – AFNET 4 study population revealed early initiation of rhythm control ...

Home August 03, 2021
Home
News | EP Lab

August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation ...

Home August 03, 2021
Home
Subscribe Now